These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 19429855

  • 1. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
    Feo F, Frau M, Tomasi ML, Brozzetti S, Pascale RM.
    Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
    [Abstract] [Full Text] [Related]

  • 2. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
    Calvisi DF, Pinna F, Ladu S, Pellegrino R, Muroni MR, Simile MM, Frau M, Tomasi ML, De Miglio MR, Seddaiu MA, Daino L, Sanna V, Feo F, Pascale RM.
    Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
    Calvisi DF, Pinna F, Pellegrino R, Sanna V, Sini M, Daino L, Simile MM, De Miglio MR, Frau M, Tomasi ML, Seddaiu MA, Muroni MR, Feo F, Pascale RM.
    Int J Cancer; 2008 Nov 01; 123(9):2057-64. PubMed ID: 18697198
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, Casabona D, Frau M, Seddaiu MA, Feo F.
    Hepatology; 2002 Jun 01; 35(6):1341-50. PubMed ID: 12029619
    [Abstract] [Full Text] [Related]

  • 10. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
    Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M, De Miglio MR, Tomasi ML, Sanna V, Muroni MR, Feo F, Pascale RM.
    Gut; 2009 May 01; 58(5):679-87. PubMed ID: 19136513
    [Abstract] [Full Text] [Related]

  • 11. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX.
    Ai Zheng; 2005 Jun 01; 24(6):757-68. PubMed ID: 15946497
    [Abstract] [Full Text] [Related]

  • 12. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
    Pascale RM, Simile MM, Calvisi DF, Frau M, Muroni MR, Seddaiu MA, Daino L, Muntoni MD, De Miglio MR, Thorgeirsson SS, Feo F.
    Hepatology; 2005 Dec 01; 42(6):1310-9. PubMed ID: 16317707
    [Abstract] [Full Text] [Related]

  • 13. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
    Frau M, Tomasi ML, Simile MM, Demartis MI, Salis F, Latte G, Calvisi DF, Seddaiu MA, Daino L, Feo CF, Brozzetti S, Solinas G, Yamashita S, Ushijima T, Feo F, Pascale RM.
    Hepatology; 2012 Jul 01; 56(1):165-75. PubMed ID: 22318685
    [Abstract] [Full Text] [Related]

  • 14. Molecular pathogenesis of hepatocellular carcinoma.
    Wong CM, Ng IO.
    Liver Int; 2008 Feb 01; 28(2):160-74. PubMed ID: 18069974
    [Abstract] [Full Text] [Related]

  • 15. Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat.
    De Miglio MR, Virdis P, Calvisi DF, Frau M, Muroni MR, Simile MM, Daino L, Careddu GM, Sanna-Passino E, Pascale RM, Feo F.
    Cancer Res; 2006 Nov 01; 66(21):10384-90. PubMed ID: 17079458
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM.
    Curr Opin Gastroenterol; 2009 May 01; 25(3):186-94. PubMed ID: 19387255
    [Abstract] [Full Text] [Related]

  • 20. The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease.
    Calvisi DF, Pinna F, Ladu S, Muroni MR, Frau M, Demartis I, Tomasi ML, Sini M, Simile MM, Seddaiu MA, Feo F, Pascale RM.
    Int J Cancer; 2010 Mar 01; 126(5):1275-81. PubMed ID: 19533683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.